9-aminomethyl substituted minocycline compounds

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 3,10-dihydroxy-2-naphthacene carboxamide or derivative doai

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C552S205000

Reexamination Certificate

active

07553828

ABSTRACT:
The present invention pertains, at least in part, to novel 9-substituted minocycline compounds. These minocycline compounds can be used to treat numerous tetracycline compound-responsive states, such as bacterial infections and neoplasms, as well as other known applications for minocycline and minocycline compounds in general, such as blocking tetracycline efflux and modulation of gene expression.

REFERENCES:
patent: 3007965 (1961-11-01), Growich
patent: 3226436 (1965-12-01), Petisi et al.
patent: RE26253 (1967-08-01), Petisi et al.
patent: 3338963 (1967-08-01), Petisi et al.
patent: RE26271 (1967-09-01), Boothe et al.
patent: 3341585 (1967-09-01), Bitha et al.
patent: 3345379 (1967-10-01), Martell, Jr. et al.
patent: 3345410 (1967-10-01), Winterbottom
patent: 3360561 (1967-12-01), Zambrano
patent: 3373193 (1968-03-01), Schroeder et al.
patent: 3397230 (1968-08-01), Winterbottom et al.
patent: 3454697 (1969-07-01), Joyner et al.
patent: 3483251 (1969-12-01), Zambrano
patent: 3518306 (1970-06-01), Martell, Jr.
patent: 3579579 (1971-05-01), Hlavka et al.
patent: 3901942 (1975-08-01), Bernardi et al.
patent: 4018889 (1977-04-01), Armstrong
patent: 4024272 (1977-05-01), Rogalski et al.
patent: 4126680 (1978-11-01), Armstrong
patent: 5248797 (1993-09-01), Sum
patent: 5281628 (1994-01-01), Hlavka et al.
patent: 5284963 (1994-02-01), Sum et al.
patent: 5326759 (1994-07-01), Hlavka et al.
patent: 5328902 (1994-07-01), Sum et al.
patent: 5371076 (1994-12-01), Lee et al.
patent: 5380888 (1995-01-01), Sum et al.
patent: 5386041 (1995-01-01), Sum et al.
patent: 5401729 (1995-03-01), Sum et al.
patent: 5401863 (1995-03-01), Hlavka et al.
patent: 5420272 (1995-05-01), Sum et al.
patent: 5430162 (1995-07-01), Sum et al.
patent: 5442059 (1995-08-01), Sum et al.
patent: 5457096 (1995-10-01), Sum et al.
patent: 5466684 (1995-11-01), Sum et al.
patent: 5494903 (1996-02-01), Hlavka et al.
patent: 5495018 (1996-02-01), Sum et al.
patent: 5495030 (1996-02-01), Sum et al.
patent: 5495031 (1996-02-01), Sum et al.
patent: 5512553 (1996-04-01), Sum et al.
patent: 5529990 (1996-06-01), Hlavka et al.
patent: 5530117 (1996-06-01), Hlavka et al.
patent: 5567692 (1996-10-01), Sum et al.
patent: 5574026 (1996-11-01), Backer et al.
patent: 5639742 (1997-06-01), Lee et al.
patent: 5675030 (1997-10-01), Krishnan et al.
patent: 5834450 (1998-11-01), Su
patent: 5843925 (1998-12-01), Backer et al.
patent: 5856315 (1999-01-01), Backer et al.
patent: 5886175 (1999-03-01), Sum et al.
patent: 6500812 (2002-12-01), Nelson et al.
patent: 6506740 (2003-01-01), Ashley et al.
patent: 6617318 (2003-09-01), Nelson et al.
patent: 6624168 (2003-09-01), Nelson et al.
patent: 6642270 (2003-11-01), Nelson et al.
patent: 6683068 (2004-01-01), Nelson et al.
patent: 6818634 (2004-11-01), Nelson et al.
patent: 6818635 (2004-11-01), Nelson et al.
patent: 6833365 (2004-12-01), Levy et al.
patent: 6841546 (2005-01-01), Draper et al.
patent: 6846939 (2005-01-01), Nelson et al.
patent: 7001918 (2006-02-01), Huss et al.
patent: 7045507 (2006-05-01), Draper et al.
patent: 7056902 (2006-06-01), Nelson et al.
patent: 7067681 (2006-06-01), Nelson et al.
patent: 7094806 (2006-08-01), Nelson
patent: 2002/0103171 (2002-08-01), Nelson et al.
patent: 2002/0111335 (2002-08-01), Nelson et al.
patent: 2002/0115644 (2002-08-01), Levy et al.
patent: 2002/0193354 (2002-12-01), Nelson et al.
patent: 2003/0100017 (2003-05-01), Draper et al.
patent: 2003/0125348 (2003-07-01), Nelson et al.
patent: 2003/0166585 (2003-09-01), Draper et al.
patent: 2004/0033996 (2004-02-01), Nelson et al.
patent: 2004/0048835 (2004-03-01), Nelson et al.
patent: 2004/0063674 (2004-04-01), Levy et al.
patent: 2004/0092490 (2004-05-01), Draper et al.
patent: 2004/0138183 (2004-07-01), Nelson et al.
patent: 2004/0152674 (2004-08-01), Levy et al.
patent: 2004/0157806 (2004-08-01), Nelson et al.
patent: 2004/0176334 (2004-09-01), Nelson et al.
patent: 2004/0192657 (2004-09-01), Garcia-Luzón et al.
patent: 2004/0214800 (2004-10-01), Levy et al.
patent: 2004/0214801 (2004-10-01), Nelson et al.
patent: 2004/0242548 (2004-12-01), Draper et al.
patent: 2004/0266740 (2004-12-01), Huss et al.
patent: 2005/0020545 (2005-01-01), Draper et al.
patent: 2005/0026875 (2005-02-01), Nelson et al.
patent: 2005/0038002 (2005-02-01), Nelson et al.
patent: 2005/0137174 (2005-06-01), Ohemeng et al.
patent: 2005/0143352 (2005-06-01), Nelson et al.
patent: 2005/0187198 (2005-08-01), Nelson et al.
patent: 2005/0215532 (2005-09-01), Levy et al.
patent: 2005/0250744 (2005-11-01), Levy et al.
patent: 2005/0282787 (2005-12-01), Myers et al.
patent: 2006/0084634 (2006-04-01), Huss et al.
patent: 2006/0089336 (2006-04-01), Nelson et al.
patent: 2006/0160799 (2006-07-01), Alekshun
patent: 2006/0166944 (2006-07-01), Berniac
patent: 2006/0166945 (2006-07-01), Abato
patent: 2006/0194773 (2006-08-01), Levy
patent: 535346 (1993-04-01), None
patent: 536515 (1993-04-01), None
patent: 582788 (1994-02-01), None
patent: 582789 (1994-02-01), None
patent: 582790 (1994-02-01), None
patent: 582810 (1994-02-01), None
patent: 582829 (1994-02-01), None
patent: 618190 (1994-10-01), None
patent: 921252 (1963-03-01), None
patent: 955766 (1964-04-01), None
patent: WO-95/22529 (1995-08-01), None
patent: WO 95/22529 (1995-08-01), None
patent: WO 96/34852 (1996-11-01), None
patent: WO 00/28983 (2000-05-01), None
patent: WO 01/19784 (2001-03-01), None
patent: WO 01/74761 (2001-10-01), None
patent: WO 01/87823 (2001-11-01), None
patent: WO 02/04406 (2002-01-01), None
patent: WO 02/04406 (2002-01-01), None
patent: WO 02/04407 (2002-01-01), None
patent: WO 02/04407 (2002-01-01), None
patent: WO 02/072022 (2002-09-01), None
patent: WO 02/072031 (2002-09-01), None
Baldini, M., et al. “Diazo derivatives of amino acids and peptides as possible antineoplastic chemotherapeutic agents. 1. General considerations and methods.”Boll Soc Ital Biol Sper. Jun. 30, 1960; 36:577-81.
Branceni, D., et al. “Use of tetracycline for the demonstration of the phenomena of extra-osseous calcification.”C.R. Seances Soc Biol Fil. 1961; 155:1469-72.
Cope, et al. N,N-Dimethylcyclohexylmethylamine.Org. Syn. Coll. vol. 4. 1963; 339-44.
Federal Register. 1962; 27:3851.
Garrod, L.P. “Recent developments in antibiotic therapy.”Recenti Prog Med. Jan. 1962; 32:3-24.
Genazzini, E., et al.Atti. Soc. Ital. Sci. Vet. 1964; 18:175-8.
Good, W. “The inhibition of haemolysis by phloridzin.”Biochim Biophys Acta. Jan. 29, 1962; 56:359-61.
Hajdu, P.Arzneimittel-Forsch. 1962; 12:206-7.
Lucier, et al. N-Methylbutylamine.Org. Syn. Coll. vol. 5. 1973; 736.
Maniar, A., et al. “One of the factors influencing the action of antibiotics.”Ann Inst Pasteur(Paris). Dec. 1961; 101:887-97.
Martell, et al.J. Med. Chem. 1967; 10(3);359-63.
Ritzerfeld, W., et al. “In vitro studies on 2 old and 2 new tetracycline preparations.”Arzneimittelforschung. Jan. 1962; 12:30-2.
Roe, et al. Fatty Acid Amides: I. Preparation of Amides of Oleic and the 9,10-Dihydroxystearic Acids.J. Am. Chem. Soc. 71. 1949; 2215-18.
Spezial, et al. N,N-Diethyl-1,2,2-Trichlorovinylamine.Org. Syn. Coll. vol. 5. 1973; 387.
Stevens, et al. Studies on the Synthesis of Vitamin B12.J. Am. Chem. Soc. 108. 1986; 1039-1049.
Strel'nokov. Effect of Tetracyclines on the Heart in Experiments by the Data of Electrocardiograms.Antibiotiki. 1965; 10(7):650-6.
van den Bogert, et al. “Doxycycline in combination chemotherapy of a rat leukemia.”Cancer Res. Dec. 1, 1988; 48(23):6686-90.
Barden, Timothy C. et al, “Glycylcyclines'. 3.9-AMinodoxycyclinecarboxamides,”J. Med. Chem., vol. 37:3205-3211 (1994).
Kaza, Darrell J. et al, “Synthesis and Biological Evaluation of 9-Substituted Tetracycline Derivatives,”Bioorganic&Medicinal Chemistry Letters, vol. 12:2163-2165 (2002).
Petersen, P.J. et al, “in Vitro and In Vivo Antibacterial Activities of a Novel Glycylcycline, the 9-t-Butylglycylamido Derivative of Minocycline (GAR-936),”Antimicrobial Agents and Chemotherapy, vol. 43(4):738-744 (1999).
Sum, Pahik-Eng

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

9-aminomethyl substituted minocycline compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 9-aminomethyl substituted minocycline compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 9-aminomethyl substituted minocycline compounds will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4145276

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.